These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35213427)

  • 21. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.
    Ozminkowski RJ; Marder WD; Hawkins K; Wang S; Stallings SC; Finkelstein SN; Sinskey AJ; Wierz D
    Clin Ther; 2004 Aug; 26(8):1341-54. PubMed ID: 15476915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying Balance Billing for Out-of-Network Behavioral Health Care in Employer-Sponsored Insurance.
    Friedman SA; Xu H; Azocar F; Ettner SL
    Psychiatr Serv; 2022 Sep; 73(9):1019-1026. PubMed ID: 35319917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study: Impact on Quantitative Treatment Limits.
    Thalmayer AG; Friedman SA; Azocar F; Harwood JM; Ettner SL
    Psychiatr Serv; 2017 May; 68(5):435-442. PubMed ID: 27974003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE; Cox ER
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments study.
    Hsu J; Price M; Brand R; Ray GT; Fireman B; Newhouse JP; Selby JV
    Health Serv Res; 2006 Oct; 41(5):1801-20. PubMed ID: 16987303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of satisfaction of health plan members with prescription drug benefits.
    Motheral BR; Heinle SM
    Am J Health Syst Pharm; 2004 May; 61(10):1007-14. PubMed ID: 15160776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.
    Dormuth CR; Neumann P; Maclure M; Glynn RJ; Schneeweiss S
    Med Care; 2009 May; 47(5):508-16. PubMed ID: 19365295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case study of point-of-service medical use in a managed care plan.
    Wong HS; Smithen L
    Med Care Res Rev; 1999; 56 Suppl 2():85-110. PubMed ID: 10327825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do high-deductible health plans affect price paid for childbirth?
    Cliff BQ
    Health Serv Res; 2022 Feb; 57(1):27-36. PubMed ID: 34254295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing.
    Henk HJ; Lopez JMS; Bookhart BK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):847-855. PubMed ID: 30156451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Out of Pocket Costs and Health Insurance Take-Up Rates.
    Kosteas VD; Renna F
    Appl Health Econ Health Policy; 2018 Jun; 16(3):367-380. PubMed ID: 29651779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features of employment-based health plans.
    Fronstin P
    EBRI Issue Brief; 1998 Sep; (201):1-21. PubMed ID: 10345788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug plan design incentives among Medicare prescription drug plans.
    Huskamp HA; Keating NL; Dalton JB; Chernew ME; Newhouse JP
    Am J Manag Care; 2014 Jul; 20(7):562. PubMed ID: 25295402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare Coinsurance Elasticity Coefficient Estimation Using Monthly Cross-sectional, Time-series Claims Data.
    Scoggins JF; Weinberg DA
    Health Econ; 2017 Jun; 26(6):795-801. PubMed ID: 27028798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of copayments and income on the utilization of medical care by subscribers to Japan's National Health Insurance System.
    Kupor SA; Liu YC; Lee J; Yoshikawa A
    Int J Health Serv; 1995; 25(2):295-312. PubMed ID: 7622320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.